Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Rev. panam. salud pública ; 31(1): 1-8, ene. 2012. graf, tab
Article in Spanish | LILACS | ID: lil-618461

ABSTRACT

OBJETIVO: Analizar la concentración de arsénico en agua recolectada en localidades de la provincia de Buenos Aires, Argentina, y su relación epidemiológica con factores de susceptibilidad y patologías asociadas. MÉTODOS: Se cuantificó la concentración de arsénico en 152 muestras provenientes de 52 localidades de Buenos Aires durante el período 2003-2008 mediante generación de hidruros-espectrofotometría de absorción atómica. Se construyó un índice compuesto de salud (ICS) considerando el contenido de arsénico, el porcentaje de hogares con necesidades básicas insatisfechas (NBI) y el de viviendas sin acceso al agua de red. A partir del ICS se definieron zonas de riesgo que fueron asociadas con la mortalidad por tumores malignos relacionados con el arsénico. RESULTADOS: Las concentraciones de arsénico se ubicaron en un rango amplio, desde 0,3 hasta 187 µg/L, con una mediana de 40 µg/L. El 82 por ciento de las muestras presentaron niveles de arsénico superiores al valor límite aceptable de 10 µg/L, y más de la mitad de ellas provenían de agua de red. La mortalidad promedio (defunciones/100 000 habitantes) por tumores en los departamentos estudiados fue mayor en los varones que en las mujeres: vías respiratorias (310 frente a 76), vías urinarias (44 frente a 11) y piel (21 frente a 11), respectivamente. Las regiones de mayor concentración de arsénico y pobreza, junto con la falta de agua de red, presentaron un riesgo relativo incrementado de 2 a 4 veces. CONCLUSIONES: La caracterización realizada a través del índice compuesto de salud sintetizó el riesgo sanitario de la exposición al arsénico de la población con niveles de carencia socioeconómica de una amplia región de la provincia de Buenos Aires.


OBJECTIVE: To analyze the concentration of arsenic in water collected in localities of the province of Buenos Aires, Argentina, and the epidemiological relationship of that concentration to factors of susceptibility and associated pathologies. METHODS: In 152 samples from 52 localities of Buenos Aires from 2003-2008, the concentration of arsenic was quantified through the generation of hydride spectrophotometry of atomic absorption. A composite index of health (CIH) was constructed using the content of arsenic and the percentages of households with unmet basic needs and dwellings without access to the potable water. Through the CIH, risk areas associated with mortality from malignant neoplasms related to arsenic were defined. RESULTS: Concentrations of arsenic spanned a broad range from 0.3 to 187 mg/L, with a median of 40 mg/L. Of the samples, 82 percent presented levels of arsenic higher than the acceptable limit of 10 mg/L, and more than half of those came from households with potable water connections. In the departments studied, the average mortality (deaths/100 000 inhabitants) from tumors was greater in men than in women: respiratory tract (310 versus 76), urinary tract (44 versus 11), and skin (21 versus 11), respectively. The regions with greater concentrations of arsenic and of poverty, together with the lack of potable water connections, had a two-to-four times greater risk. CONCLUSIONS: The findings from the composite index of health summarized the health risk from exposure to arsenic for lower socioeconomic levels of the population for a broad area of the province of Buenos Aires.


Subject(s)
Female , Humans , Male , Arsenic/analysis , Drinking Water/analysis , Environmental Exposure , Vulnerable Populations , Water Pollutants, Chemical/analysis , Argentina/epidemiology , Arsenic/toxicity , Housing , Poverty , Respiratory Tract Neoplasms/mortality , Risk , Skin Neoplasms/mortality , Spectrophotometry, Atomic , Urologic Neoplasms/mortality , Water Pollutants, Chemical/toxicity , Water Supply/analysis
2.
Rev. Assoc. Med. Bras. (1992) ; 53(4): 317-322, jul.-ago. 2007. graf, tab
Article in Portuguese | LILACS | ID: lil-460302

ABSTRACT

OBJETIVO: Descrever a morbidade hospitalar e a mortalidade por neoplasias no Brasil e regiões segundo gênero. MÉTODOS: Os dados de óbitos foram obtidos junto ao Sistema de Informações sobre Mortalidade e os de morbidade hospitalar no Sistema de Informações Hospitalares. Os óbitos foram categorizados segundo as localizações primárias do tumor, selecionadas de acordo com a décima revisão da Classificação Internacional de Doenças. Os dados populacionais são oriundos das estimativas intercensitárias do IBGE. O período de análise foi o triênio 2002-2004, o mais recente com dados de mortalidade no Brasil. Optou-se por calcular a média desse período para conferir maior estabilidade às taxas. RESULTADOS: Entre 2002 e 2004 ocorreram 405.415 óbitos por neoplasias no Brasil. As maiores taxas de mortalidade foram identificadas nas regiões Sul e Sudeste. Entre os homens, o câncer de traquéia, brônquios e pulmões foi a neoplasia maligna que apresentou maior mortalidade e entre as mulher foi o câncer de mama. Este agravo e o câncer de colo uterino foram os que mais demandaram internações, e a leucemia apresentou o maior custo médio e custo total em internações. CONCLUSÕES: A carga das neoplasias é extremamente elevada no Brasil e medidas públicas de caráter populacional devem ser priorizadas para o efetivo controle da morbidade e da mortalidade por este agravo.


OBJECTIVE: To describe mortality and the hospital morbidity by neoplasias in Brazil and regions according to gender. METHODS: Data of deaths were obtained from the Mortality Information System and of hospital morbidity from the Hospital Information System. Deaths were categorized according to primary tumor sites, selected in accordance with the tenth revision of the International Classification of Diseases. The population data were drawn from the inter census estimates of the IBGE (Brazilian Institute of Geography and Statistics). The period of analysis was the triennial 2002-2004, with the most recent mortality data in Brazil. The average of this period was calculated to ensure greater stability of the rates. RESULTS: Between 2002 and 2004, 405,415 deaths from neoplasias occurred in Brazil. The highest rates of mortality were identified in the South and South-East regions. For men, cancer of the trachea, bronchi and lungs were the malignant neoplasias with the highest mortality rate while for women breast cancer was highest. Breast cancer and cancer of the uterine cervix are those requiring the largest number of in-hospital admissions. In internments, leukemia presented the highest average cost and total cost. CONCLUSION: The burden of neoplasms is extremely high in Brazil and public policies focused on the population must be given priority for an effective control of mortality and morbidity.


Subject(s)
Female , Humans , Male , Hospital Mortality , Neoplasms/mortality , Brazil/epidemiology , Breast Neoplasms/economics , Breast Neoplasms/mortality , Cause of Death , Demography , Hospitalization/economics , Hospitalization/statistics & numerical data , International Classification of Diseases , Leukemia/economics , Leukemia/mortality , Morbidity , Neoplasms/economics , Respiratory Tract Neoplasms/economics , Respiratory Tract Neoplasms/mortality , Sex Distribution , Time Factors , Uterine Cervical Neoplasms/economics , Uterine Cervical Neoplasms/epidemiology
3.
Salud pública Méx ; 44(supl.1): s20-s28, 2002. graf, tab
Article in Spanish | LILACS | ID: lil-464228

ABSTRACT

Objetivo. Describir la tendencia de la mortalidad por cáncer atribuible al consumo de tabaco, particularmente neoplasias del pulmón, en México, durante el periodo 1980-1997. Material y métodos. Se hizo un análisis de tendencias de mortalidad para cada tipo de cáncer asociado con el tabaco, según la Clasificación Internacional de Enfermedades. Las tasas cruda y ajustada de mortalidad fueron estimadas en términos de edad, género, causa básica de la muerte y año, entre 1980 y 1997. Se estimó la razón de género y proporción relativa para los casos que estaban en el grupo de edad entre 35 y 64 años y para toda la población estudiada. Como denominador se utilizaron las proyecciones por edad calculadas por el Consejo Nacional de Población (1970-2010). Resultados. La razón de género para las tasas de mortalidad por cáncer de laringe, esófago, cavidad oral y faringe fue de 2.10:1.00 (hombre: mujer). La razón de género para el cáncer de laringe es enorme: 4.21: 1.00, probablemente debida a la mayor prevalencia de hombres fumadores de tabaco. La proporción relativa estimada, usando la mortalidad total debida a tumores malignos, entre 1980 y 1997 fue la siguiente: cáncer de pulmón 12.31 por ciento, laringe 1.71 por ciento, esófago 1.55 por ciento y cavidad oral/faringe 1.49 por ciento. El antecedente de tabaquismo tiene correlación con la tendencia de la tasa de mortalidad por cáncer del pulmón (Beta: 0.910, IC 95 por ciento: 1.097-1.797; R² 0.827). Para los grupos sociales mas pobres, por entidad federativa, la correlación está invertida (Beta: -0.510, IC 95 por ciento: -0.170, -0.039, R²: 0.260). Conclusiones. En México, la mejoría en el diagnóstico, la transición demográfica y el incremento del consumo de tabaco son, probablemente, los principales factores a los que se atribuye la tasa de mortalidad por cáncer. No obstante, otras variables asociadas con el estilo de vida, como urbanización, actividad física, ingesta de carotenoides y otros componentes...


Objective. To describe the mortality trends of cancer attributable to tobacco smoking, particularly lung cancer, for the 1980-1997 period in Mexico. Material and Methods. Mortality trends were analyzed for each type of cancer associated to tobacco smoking, according to the International Classification of Diseases (ICD). Crude and adjusted mortality rates were estimated for the period between 1980 and 1997, by age, gender, basic death cause, and year of death. The gender ratio and the relative proportion were estimated for cases in the 35-64 age group and for the entire study population. Age population projections by Consejo Nacional de Poblacion (National Population Council), were used as denominators (1970-2010). Results. The gender ratio for mortality rates for lung, esophageal, oral cavity and pharyngeal cancer was 2.10:1.00 (male: female). The gender ratio for laryngeal cancer was striking: 4.21:1.00, probably due to the higher prevalence of male tobacco smokers. The estimated relative proportion, using the total mortality due to malignant cancers between 1980-1997, was 12.31 percent for lung cancer, 1.71 percent for larynx cancer, 1.55 percent for esophageal cancer, and 1.49 percent for oral cavity/pharyngeal cancer. Previous tobacco smoking was correlated with the mortality rate trends for lung cancer (beta: 0.910, IC 95 percent: 1.097-1.797, R² 0.827). For the poorest social groups by federal entity, the correlation was inverted (beta: -0.510, IC 95 percent -0.170, -0.039, R²: 0.260). Conclusions. In Mexico, increased tobacco smoking, improved cancer diagnosis, and the demographic transition, are probably the main factors determining cancer mortality rates. However, other lifestyle associated variables, such as urbanization, physical activity, carotenoid intake, and other dietary and toxic substances like alcohol, may also influence the morbidity and mortality rates. Although tobacco-related cancer is a fast-growing public health...


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Head and Neck Neoplasms/etiology , Head and Neck Neoplasms/mortality , Respiratory Tract Neoplasms/etiology , Respiratory Tract Neoplasms/mortality , Tobacco/adverse effects , Mexico/epidemiology
4.
Salud pública Méx ; 29(4): 299-312, jul.-ago. 1987. tab
Article in Spanish | LILACS | ID: lil-65469

ABSTRACT

En este artículo se presenta un análisis estadístico de la mortalidad femenina por cáncer durante el período 1967-1981 en México. También se estudia su distribución por órganos y grupos de edad de alto riesgo. Se hace referencia a los métodos de prevención primaria y secundaria para los seis tipos más frecuentes de cáncer. Los cánceres cérvico uterino y de mama, aunque pueden detectarse oportunamente, siguen ocupando los primeros lugares como causa de mortalidad, lo que los convierte en un problema de salud pública. Finalmente, se sugieren estrategias y metas para abatir su incidencia


Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , Uterine Neoplasms/mortality , Breast Neoplasms/mortality , Leukemia/epidemiology , Genital Neoplasms, Female/epidemiology , Lymphoma/epidemiology , Stomach Neoplasms/mortality , Risk Factors , Mexico , Respiratory Tract Neoplasms/mortality
SELECTION OF CITATIONS
SEARCH DETAIL